Trends in Use of Medication to Treat Opioid Use Disorder during the COVID-19 Pandemic in 10 State Medicaid Programs
06/16/2023
Federal and state agencies granted temporary regulatory waivers to prevent disruptions in access to medication for opioid use disorder (MOUD) during the COVID-19 pandemic, including expanding access to telehealth for MOUD. To examine changes in MOUD receipt and initiation among Medicaid enrollees during the pandemic, this serial cross-sectional study included Medicaid enrollees aged 18 to 64 years in 10 states from May 2019 through December 2020.
Senior Policy Analyst Shamis Mohamoud co-authored this article published in JAMA Health Forum.